Advancing Clinical Research With Integrity: The StatisticaMedica Story
Founding and vision
It has been more than a decade since StatisticaMedica began its journey in the field of clinical research. Founded in 2012 in Dublin, Ireland, by Dr. Gloria Crispino—a biostatistician with more than fifteen years of experience — it has developed into a niche boutique biostatistical contract research organization that provides first-class biostatistical support to its clients. The company excels in design, data analysis, and clinical trial reporting across various sectors, including academia, the global pharmaceutical market, the medical device business, and the healthcare industry.?
From its Irish roots, StatisticaMedica has expanded to Italy and the UK, becoming a globally recognized organization. They've stayed true to their mission of helping make sense of complex medical data, all while growing their reach and impact. Their journey shows how expertise and dedication can turn a niche service into a valuable resource for the entire healthcare industry.
What about technology?
StatisticaMedica is at the forefront of clinical trial innovation, employing advanced technologies to enhance every step of the process. Their suite of sophisticated statistical software enables precise data analysis, while state-of-the-art machine learning algorithms boost their predictive modeling capabilities.
A key component of their technological arsenal is a secure cloud-based platform, facilitating seamless data management and real-time collaboration. This infrastructure allows the company to efficiently handle large, complex datasets and conduct intricate analyses with remarkable speed and accuracy.
The company’s approach combines academic insights with practical application. This results in faster, more accurate clinical trials. For pharmaceutical and biotech companies, this means quicker development of new treatments and better use of resources. By streamlining the research process, the CRO helps bring new medicines to patients more quickly.?
领英推荐
Distinctive service offering
What sets StatisticaMedica apart is its personalized approach to clinical research. The company offers comprehensive end-to-end services, including trial design, data collection, analysis, and regulatory submission. Their expertise spans various therapeutic areas, including cardiovascular, respiratory, neurology, oncology, dermatology, and urology. With a deep understanding of regulatory landscapes across multiple countries, they tailor their services to meet each client's unique needs. This personalized attention, combined with their global reach, makes the company a leader in biostatistical consulting.
Dr. Gloria Crispino, the CEO and head of biostatistics at the company, really gets to the heart of what the company is all about. She puts it this way:
“Together, we ensure that your data provide critical insights, and your submissions meet all regulatory requirements, bringing complete competence and absolute integrity to your clinical trial."
Future horizons
The biostatistical CRO is to enhance its predictive modeling and data analysis services by investing in artificial intelligence and big data analytics. They are also expanding globally, planning new offices to work more closely with drug companies and research labs worldwide. Their goal is simple: be the best partner for developing new medicines. They're committed to making the process of creating new medicines faster and more efficient, potentially speeding up the delivery of treatments to patients.
?
?
?